Saturday 17 October 2026
Export CERT’s income statement to Excel — free account
Certara, Inc.
CERT Healthcare Health Information Services
In the quarter to June 2026, revenue was flat, EPS fell 3,500.0%, free cash flow fell 78.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
9.37
0.29
−3.00%
Follow CERT
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 5 | 5 | 7 | 4 | 4 | 6 |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 161.75 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | 6.34 | 5.73 | 3.48 | 3.45 | 2.24 | 2.04 |
P/S ratio |
— | 0.00 | 0.00 | 18.45 | 14.88 | 7.59 | 7.78 | 4.44 | 3.37 |
Altman Z″-Score (non-manufacturers) |
— | 0.87 | 1.19 | 3.04 | 3.02 | 3.31 | 2.59 | 2.57 | 2.76 |
P/FCF ratio |
— | 111.59 | 111.59 | 121.85 | 82.71 | 31.84 | 40.86 | 28.75 | 20.25 |
Beneish M-Score |
— | — | (2.63) | (2.78) | (2.36) | (2.53) | (2.93) | (2.58) | (2.77) |
P/Operating CF |
— | 325.55 | 325.55 | 354.32 | 204.43 | 71.80 | 118.22 | 34.60 | 49.04 |
P/B ratio |
— | 10.13 | 10.13 | 5.47 | 4.09 | 2.36 | 2.63 | 1.61 | 1.33 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | 0.00 | 0.00 | 18.55 | 15.26 | 7.75 | 7.94 | 4.74 | 3.62 |
EV/EBITDA |
— | 0.00 | 0.00 | 227.60 | 72.51 | 30.06 | 44.10 | 27.09 | 15.68 |
EV/Operating CF |
— | 99.13 | 99.13 | 100.84 | 72.31 | 28.11 | 34.00 | 22.67 | 15.75 |
EV/FCF |
— | 119.28 | 119.28 | 122.54 | 84.81 | 32.51 | 41.69 | 30.70 | 21.74 |
Quick Ratio |
— | 0.90 | 1.26 | 4.35 | 2.78 | 3.12 | 2.46 | 1.93 | 1.91 |
Current Ratio |
— | 1.05 | 1.39 | 4.60 | 2.98 | 3.32 | 2.62 | 2.13 | 2.05 |
Net Debt/EBITDA |
— | 11.68 | 5.93 | 1.28 | 1.80 | 0.62 | 0.88 | 1.73 | 1.07 |
Debt/Assets |
0.00% | 38.80% | 38.70% | 23.54% | 19.50% | 18.63% | 18.63% | 18.76% | 18.83% |
Debt/Equity |
— | 0.83 | 0.82 | 0.36 | 0.28 | 0.27 | 0.28 | 0.28 | 0.28 |
Asset Turnover |
— | 0.31 | 0.20 | 0.21 | 0.21 | 0.22 | 0.23 | 0.25 | 0.27 |
Operating CF/Net income |
— | (0.35) | (4.26) | (0.91) | (4.55) | 6.28 | (1.49) | (6.68) | (60.39) |
Capex/Depreciation |
— | (0.30) | (0.22) | (0.18) | (0.19) | (0.23) | (0.15) | (0.30) | (0.35) |
Interest Coverage |
— | (0.17) | 0.70 | (0.97) | 0.81 | 1.83 | (1.78) | (0.08) | 1.06 |
| — | (6.75%) | (1.81%) | (7.52%) | (1.42%) | 1.39% | (5.21%) | (1.14%) | (0.15%) | |
| — | (6.33%) | (0.85%) | (4.28%) | (0.95%) | 0.96% | (3.53%) | (0.77%) | (0.10%) | |
ROIC |
— | (0.33%) | 1.42% | (1.80%) | 0.74% | 1.79% | (2.31%) | (0.09%) | 1.13% |
Return on Tangible Assets |
— | (374.53%) | (30.63%) | (17.96%) | (7.15%) | 6.10% | (26.01%) | (7.22%) | (0.98%) |
Average Days of Receivables |
— | 103.65 | 86.90 | 81.07 | 88.74 | 89.81 | 87.41 | 96.84 | 90.22 |
Research and Development Expense of Revenue |
— | 6.40% | 5.58% | 8.07% | 7.12% | 8.40% | 9.64% | 9.63% | 9.80% |
Selling, General and Administrative Expense of Revenue |
— | 32.26% | 28.13% | 44.22% | 34.84% | 29.55% | 35.96% | 36.78% | 33.21% |
Intangible Assets out of Total Assets |
0.00 | 0.93 | 0.91 | 0.72 | 0.80 | 0.77 | 0.77 | 0.79 | 0.78 |
Share Based Compensation of Revenue |
— | 1.05% | 0.81% | 26.49% | 10.30% | 9.04% | 7.99% | 9.03% | 7.90% |
Graham Net Nets |
— | (0.09) | (0.09) | (0.02) | (0.05) | (0.06) | (0.06) | (0.12) | (0.13) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 3.94 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (1.07%) | (1.07%) | (1.07%) | (0.29%) | 0.62% | (2.02%) | (0.75%) | (0.11%) |
Free Cash Flow Yield |
— | 0.90% | 0.90% | 0.82% | 1.21% | 3.14% | 2.45% | 3.48% | 4.94% |
Revenue per Share |
— | 1.24 | 1.57 | 1.83 | 1.91 | 2.14 | 2.23 | 2.40 | 2.61 |
Operating CF per Share |
— | 0.09 | 0.29 | 0.34 | 0.40 | 0.59 | 0.52 | 0.50 | 0.60 |
Capex per Share |
— | (0.09) | (0.07) | (0.06) | (0.06) | (0.08) | (0.10) | (0.13) | (0.17) |
Free Cash Flow per Share |
— | 0.00 | 0.22 | 0.28 | 0.34 | 0.51 | 0.42 | 0.37 | 0.44 |
Cash per Share |
— | 0.09 | 0.22 | 2.05 | 1.25 | 1.53 | 1.48 | 1.12 | 1.18 |
Shareholders Equity per Share |
— | 3.72 | 3.72 | 6.17 | 6.95 | 6.88 | 6.59 | 6.60 | 6.63 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 3.72 | 3.72 | 6.17 | 6.95 | 6.88 | 6.59 | 6.60 | 6.63 |
Free Cash Flow |
— | 0.11 | 28.51 | 36.87 | 51.49 | 80.01 | 67.49 | 59.43 | 69.77 |
Working Capital |
— | 3.48 | 24.52 | 271.24 | 182.50 | 239.09 | 210.18 | 164.76 | 161.73 |
Capital Expenditures |
— | (11.48) | (9.52) | (7.94) | (8.90) | (12.53) | (15.27) | (21.04) | (26.56) |
Net Current Asset Value |
— | (489.79) | (457.50) | (100.68) | (195.15) | (151.01) | (176.10) | (205.60) | (178.67) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 321.58 | 79.98 | 0.00 | 0.00 | 72.17 |
Capex to Sales |
— | 0.07 | 0.05 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | 0.06 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 313.61 | 78.34 | 0.00 | 0.00 | 67.24 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 7.13 | 9.32 | 11.43 | 15.89 | 22.50 | 39.17 | 31.87 | 40.87 |
Cash ROIC |
— | 0.01% | 3.09% | 2.64% | 3.38% | 4.96% | 4.29% | 3.88% | 4.51% |
Accounts Receivable Turnover |
— | 3.41 | 4.34 | 4.70 | 4.63 | 4.41 | 4.23 | 4.12 | 4.07 |
Accounts Payable Turnover |
— | 14.46 | 16.24 | 17.82 | 16.12 | 17.69 | 22.20 | 35.63 | 46.51 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 25.22 | 22.50 | 23.16 | 24.39 | 20.74 | 13.38 | 8.27 | 7.76 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 48.07 | 48.07 | 51.87 | 61.82 | 76.07 | 83.72 | 93.52 | 102.86 |
Average Payables |
— | 4.91 | 4.91 | 5.66 | 6.93 | 7.50 | 6.35 | 4.34 | 3.46 |
Average Assets |
— | 525.75 | 1,044.28 | 1,153.23 | 1,390.57 | 1,542.33 | 1,568.03 | 1,569.12 | 1,565.84 |
Average Common Equity |
— | 492.41 | 492.41 | 657.09 | 931.99 | 1,060.76 | 1,063.25 | 1,052.75 | 1,060.73 |
Columns are period end dates